Efficacy and safety of nirogacestat in patients with desmoid tumor and adenomatous polyposis coli (APC) mutation: Phase 3 DeFi analyses
Publication
, Conference
Kasper, B; Federman, N; Reichardt, P; Attia, S; Lim, A; Amoruccio, V; Cho, S; Riedel, RF
Published in: JOURNAL OF CLINICAL ONCOLOGY
2024
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2024
Volume
42
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kasper, B., Federman, N., Reichardt, P., Attia, S., Lim, A., Amoruccio, V., … Riedel, R. F. (2024). Efficacy and safety of nirogacestat in patients with desmoid tumor and adenomatous polyposis coli (APC) mutation: Phase 3 DeFi analyses. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).
Kasper, Bernd, Noah Federman, Peter Reichardt, Steven Attia, Allison Lim, Vincent Amoruccio, Sunny Cho, and Richard F. Riedel. “Efficacy and safety of nirogacestat in patients with desmoid tumor and adenomatous polyposis coli (APC) mutation: Phase 3 DeFi analyses.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.
Kasper B, Federman N, Reichardt P, Attia S, Lim A, Amoruccio V, et al. Efficacy and safety of nirogacestat in patients with desmoid tumor and adenomatous polyposis coli (APC) mutation: Phase 3 DeFi analyses. In: JOURNAL OF CLINICAL ONCOLOGY. 2024.
Kasper, Bernd, et al. “Efficacy and safety of nirogacestat in patients with desmoid tumor and adenomatous polyposis coli (APC) mutation: Phase 3 DeFi analyses.” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.
Kasper B, Federman N, Reichardt P, Attia S, Lim A, Amoruccio V, Cho S, Riedel RF. Efficacy and safety of nirogacestat in patients with desmoid tumor and adenomatous polyposis coli (APC) mutation: Phase 3 DeFi analyses. JOURNAL OF CLINICAL ONCOLOGY. 2024.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2024
Volume
42
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences